Driss Cherqaoui

905 total citations
60 papers, 693 citations indexed

About

Driss Cherqaoui is a scholar working on Computational Theory and Mathematics, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Driss Cherqaoui has authored 60 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Computational Theory and Mathematics, 24 papers in Organic Chemistry and 18 papers in Molecular Biology. Recurrent topics in Driss Cherqaoui's work include Computational Drug Discovery Methods (29 papers), Synthesis and biological activity (15 papers) and HIV/AIDS drug development and treatment (11 papers). Driss Cherqaoui is often cited by papers focused on Computational Drug Discovery Methods (29 papers), Synthesis and biological activity (15 papers) and HIV/AIDS drug development and treatment (11 papers). Driss Cherqaoui collaborates with scholars based in Morocco, France and United States. Driss Cherqaoui's co-authors include Didier Villemin, Abdellah Jarid, Andreea R. Schmitzer, J. M. Cense, Mahmoud E. S. Soliman, Mohamed Maatallah, Driss Zakarya, M. Esseffar, Joel F. Liebman and Vladimı́r Kvasnička and has published in prestigious journals such as Scientific Reports, Chemosphere and International Journal of Molecular Sciences.

In The Last Decade

Driss Cherqaoui

53 papers receiving 659 citations

Peers

Countries citing papers authored by Driss Cherqaoui

Since Specialization

Citations

This map shows the geographic impact of Driss Cherqaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Driss Cherqaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Driss Cherqaoui more than expected).

Fields of papers citing papers by Driss Cherqaoui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Driss Cherqaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Driss Cherqaoui. The network helps show where Driss Cherqaoui may publish in the future.

Co-authorship network of co-authors of Driss Cherqaoui

This figure shows the co-authorship network connecting the top 25 collaborators of Driss Cherqaoui. A scholar is included among the top collaborators of Driss Cherqaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Driss Cherqaoui. Driss Cherqaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1,2,4-triazolo-1,5-benzodiazepine diastereoisomers: Synthesis, structural elucidation and computational insights for anti-ebola activity 2025 ·Journal of Molecular Structure ·(unknown), (unknown), (unknown), Ashwag S. Alanazi, (unknown), (unknown), Mohamed Adardour, (unknown), Karim Chkirate, Joel T. Mague, Driss Cherqaoui, A. Baouid	0
2	Design, synthesis and molecular modeling of new Pyrazolyl-Benzimidazolone hybrids targeting breast Cancer 2025 ·Bioorganic Chemistry ·Mohamed Adardour, (unknown), (unknown), (unknown), (unknown), (unknown), Elena Zaballos-Garcı́a, Joel T. Mague, (unknown), Driss Cherqaoui, Oliver H. Krämer, Wolfgang Sippl, Hany S. Ibrahim, A. Baouid	1
3	Drug design of new anti-EBOV inhibitors: QSAR, homology modeling, molecular docking and molecular dynamics studies 2024 ·Arabian Journal of Chemistry ·(unknown), (unknown), (unknown), (unknown), Youssef Habibi, Ashwag S. Alanazi, Mohammed M. Alanazi, Christelle Delaite, Mohamed Maatallah, Driss Cherqaoui	6
4	Deciphering the cytotoxic and antioxidant potential of 3,5-disubstituted isoxazole-linked benzimidazolone derivatives 2024 ·Journal of Molecular Structure ·Mohamed Adardour, (unknown), (unknown), (unknown), Elena Zaballos-Garcı́a, Mohammed M. Alanazi, (unknown), Karim Chkirate, Driss Cherqaoui, Joel T. Mague, A. Baouid	2
5	New Schiff bases and their vanadium complexes: Synthesis, characterization, and biological assessment for antibacterial and antiviral action 2024 ·Applied Organometallic Chemistry ·(unknown), A. Hasnaoui, (unknown), (unknown), (unknown), (unknown), Joel T. Mague, Johan Neyts, Dirk Jochmans, Driss Cherqaoui, Larbi El Firdoussi, Naı̈ma Fdil, Hassan B. Lazrek, Mustapha Ait Ali	7
6	Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations 2023 ·Pharmaceuticals ·(unknown), (unknown), Christelle Delaite, Adlane Sayede, Driss Cherqaoui, Achraf El Allali	12
7	Crystal Structure, DFT Calculation, and Hirshfeld Surface Analysis of the 1-(Cyclohex-1-en-1-yl)-3-(prop-2-yn-1-yl)-1,3-dihydro-2H-benzimidazol-2-one 2023 ·Crystals ·Mohamed Adardour, (unknown), (unknown), Mohammed M. Alanazi, (unknown), (unknown), Solenne Fleutot, Michel François, Driss Cherqaoui, A. Baouid	5
8	Syntheses, characterization and DFT studies of two new (π-allyl) palladium(II) complexes of β-8,9-dihydrohimachalene 2023 ·Journal of Coordination Chemistry ·(unknown), (unknown), (unknown), (unknown), Mohamed Saadi, Lahcen El Ammari, (unknown), Driss Cherqaoui, (unknown), Abdallah Karim	2
9	Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants 2023 ·Pharmaceuticals ·Mohamed Adardour, (unknown), (unknown), Walid Ettahiri, (unknown), Hafida Bouamama, Mohammed M. Alanazi, Driss Cherqaoui, Mustapha Taleb, Elena Zaballos-Garcı́a, A. Baouid	23
10	Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview 2022 ·Current Topics in Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Didier Villemin, Rachid Daoud, Achraf El Allali, Driss Cherqaoui	11
11	Design, Synthesis, Biological and Computational Assessment of New Thiazolidin‐4‐one Derivatives as Potential Anticancer Agents Through the Apoptosis Pathway 2022 ·ChemistrySelect ·Abdoullah Bimoussa, Ali Oubella, (unknown), Mourad Fawzi, Yassine Laamari, My Youssef Ait Itto, (unknown), (unknown), Hamid Morjani, Driss Cherqaoui, (unknown), (unknown)	13
12	Development of QSAR Models Using Singular Value Decomposition Method: A Case Study for Predicting Anti-HIV-1 and Anti-HCV Biological Activities 2021 ·Biointerface Research in Applied Chemistry ·(unknown), (unknown), (unknown), Driss Cherqaoui	1
13	In silico design and analysis of NS4B inhibitors against hepatitis C virus 2020 ·Journal of Biomolecular Structure and Dynamics ·(unknown), (unknown), (unknown), Mahmoud E. S. Soliman, Didier Villemin, Driss Cherqaoui	11
14	Synthesis of diverse isoxazolylamino-2-(aryl)acetamides using one-pot Multicomponent Reactions: X-ray, Hirshfeld analysis and DFT modeling 2019 ·Journal of Molecular Structure ·(unknown), (unknown), (unknown), (unknown), (unknown), Driss Cherqaoui, Joel T. Mague	7
15	Exploring the Structural Mechanism of Covalently Bound E3 Ubiquitin Ligase: Catalytic or Allosteric Inhibition? 2018 ·The Protein Journal ·(unknown), Shama Khan, Robin M. Betz, Driss Cherqaoui, Mahmoud E. S. Soliman	9
16	The hyperconjugation effect on the graphene counterparts based on silicon and germanium 2017 ·Current Applied Physics ·(unknown), (unknown), Mohamed Maatallah, Driss Cherqaoui, Abdellah Jarid	4
17	Large gallanes and the PSEPT theory: a theoretical study of Ga n H n+2 clusters (n = 7–9) 2012 ·Journal of Molecular Modeling ·Mohamed Maatallah, Driss Cherqaoui, Abdellah Jarid, Joel F. Liebman	8
18	Quality of life after double total knee arthroplasty on hemophilic arthropathy: Two case reports 2011 ·Annals of Physical and Rehabilitation Medicine ·(unknown), Driss Cherqaoui, (unknown), (unknown), (unknown)	0
19	Comparative QSAR Based on Neural Networks for the Anti-HIV Activity of HEPT Derivatives 2003 ·Current Pharmaceutical Design ·(unknown), Didier Villemin, Driss Cherqaoui	23
20	Application of neural networks to quantitative structure-antifungal activity relationships of 1-[1-(substituted phenyl)vinyl]imidazoles. 2000 ·Fresenius environmental bulletin ·(unknown), Didier Villemin, (unknown), A. Jaouad, Driss Cherqaoui	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact